Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 9, 2013, Pages 1055-1065

  Wang, Chao ^a   Jin, Mei Shan ^a   Zou, Ya Bin ^a   Gao, Jing Na ^a   Li, Xiao Bo ^a   Peng, Fang ^a   Wang, Hai Ying ^a   Wu, Zhen Dong ^a   Wang, Yin Ping ^a   Duan, Xiu Mei ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

C Kit gene; CD117; DOG 1; GISTs; PDGFRA gene; PKC

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CD34 ANTIGEN; DESMIN; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; PROTEIN DOG 1; PROTEIN KINASE C; PROTEIN S 100; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MISSENSE MUTATION; MITOSIS RATE; MUSCLE TUMOR; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SPINDLE CELL; TISSUE MICROARRAY; TUMOR LOCALIZATION; TUMOR VOLUME; WILD TYPE;

ACTINS; ADULT; ANTIGENS, CD34; CHLORIDE CHANNELS; DESMIN; EXONS; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; ISOENZYMES; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84882984542     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.816770     Document Type: Article

References (41)

1. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: A randomised, double-blind, placebo-controlled trial. Lancet 2009;373:1097-104
2. Laurini JA, Carter JE. Gastrointestinal stromal tumors: A review of the literature. Arch Pathol Lab Med 2010;134: 134-41
3. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008;39: 1411-19
4. Beham AW, Schaefer IM, Schüler P, Cameron S, Michael Ghadimi B. Gastrointestinal stromal tumors. Int J Colorectal Dis 2012;27:689-700
5. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008;53:567-77
6. Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR, Lorincz A, Pozo MJ, Pasricha PJ, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009;296:G1370-81
7. Espinosa I, Lee CH, Kim MK, Rouse BT, Subrama-nian S, Montgomery K, et al. A novel monoclonal antibody against DOG1 is a sensitive and specifi c marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008;32:210-18 (Pubitemid 351172135)
8. Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology 2010;57:259-70
9. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004;165: 107-13 (Pubitemid 38821818)
10. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: A study of 1840 cases. Am J Surg Pathol 2009;33:1401-8
11. Ríos-Moreno MJ, Jaramillo S, Pereira Gallardo S, Vallejo A, Mora M, García-Escudero A, et al. CD117, DOG-1 and PKC-q expression. Is there any advantage in using several markers? Pathol Res Pract 2012;208:74-81
12. Lee CH, Liang CW, Espinosa I. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-The GIST of it. Adv Anat Pathol 2010;17:222-32
13. Fatima N, Cohen C, Siddiqui MT. DOG1 utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration. Cancer Cytopathol 2011;119:202-8
14. Kang GH, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, et al. DOG1 and PKC-q are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Mod Pathol 2011;24:866-75
15. Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: A clinicopathologic and genetic study of 10 cases. Am J Surg Pathol 2011;35:1287-95
16. Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology 2010;57:259-70
17. Kang YN, Jung HR, Hwang I. Clinicopathological and immunohistochemical features of gastointestinal stromal tumors. Cancer Res Treat 2010;42:135-43
18. Kim KM, Kang DW, Moon WS, Park JB, Park CK, Sohn JH, et al. PKC expression in gastrointestinal stromal tumor. Mod Pathol 2006;19:1480-6 (Pubitemid 44624168)
19. Lee HE, Kim MA, Lee HS, Lee BL, Kim WH. Characteristics of KIT-negative gastrointestinal stromal tumors and diagnostic utility of protein kinase C theta immunostaining. J Clin Pathol 2008;61:722-9 (Pubitemid 351859964)
20. Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, et al. Diagnostic relevance of overexpressions of PKC-q and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: A Korean six-centers study of 28 cases. Anticancer Res 2012;32:923-37
21. Kang GH, Kim KM, Park CK, Kang DY. PKC-Theta expression in Ewing sarcoma primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour. Histopathology 2009;55:353-69
22. Wong NA, Shelley-Fraser G. Specificity of DOG1 (K9 clone) and protein kinase C theta (clone27)as immunohistochemical markers of gastrointestinal stromal tumour. Histopathology 2010;57:250-8
23. Kang GH, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, et al. DOG1 and PKCq are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Mod Pathol 2011;24:866-75
24. Gramza AW, Corless CL, Heinrich MC. Resistance to tyrosine kinase inhibitors in gasrointestinal stromal tumors. Clin Cancer Res 2009;15:7510-18
25. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical and molecular genetic study of 1765 cases with long-Term follow-up. Am J Surg Pathol 2005;29:52-68 (Pubitemid 40023952)
26. Kontogianni-Katsarou K, Dimitriadis E, Lariou C, Kairi-Vassilatou E, Pandis N, Kondi-Paphiti A. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World J Gastroenterol 2008;14:1891-7 (Pubitemid 351523820)
27. Sekkate S, Kairouani M, Abahssain H, Serji B, Boutayeb S, et al. Gastrointestinal stromal tumors. Presse Med 2012; 1:24
28. Tan CB, Zhi W, Shahzad G, Mustacchia P. Gastrointestinal stromal tumors: A review of case reports, diagnosis, treatment, and future directions. ISRN Gastroenterol 2012;2012: 595968
29. Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, et al. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: A study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol 2005;23:6190-8
30. Miettinen M, Lasota J. Gastrointestinal stromal tumors: Review on morphology, m olecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006;130: 1466-78 (Pubitemid 44520713)
31. Liegl-Atzwanger B, Fletcher JA, Fletcher CD. Gastrointestinal stromal tumors. Virchows Arch 2010;456:111-27
32. Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol Mech Dis 2008;3:557-86 (Pubitemid 351488293)
33. Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 2008;53:245-66
34. Miettinen M, Lasota J. Gastrointestinal stromal tumors: Pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83 (Pubitemid 44692418)
35. Kang GH, Kim KM, Park CK, Kang DY. PKC-Theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumor. Histopathology 2009;55:368-9
36. Wozniak A, Rutkowski P, Piskorz A, Ciwoniuk M, Osuch C, Bylina E, et al. Polish Clinical GIST Registry.Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience. Ann Oncol 2012;23:353-60
37. Zheng S, Huang KE, Tao DY, Pan YL. Gene mutations and prognostic factors analysis in extragastrointestinal stromal tumor of a chinese three-center study. J Gastrointest Surg 2011;15:675-81
38. Pauls K, Merkelbach-Bruse S, Thal D, Buttner R, Wardelmann E. PDGFR-A and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology 2005;46:166-75 (Pubitemid 40293015)
39. Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptora gene in gastrointestinal stromal tumors. Gastroenterology 2003;125:660-7 (Pubitemid 37070684)
40. Demetri GD, von MehrenM, Antonescu CR, DeMatteo RP, Ganjoo KN,Maki RG, et al. NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 2010;8(Suppl:S1-41
41. Laperouse P, Raines D, Diamond K, Rivera S, Newman W, Hew AY Jr, et al. Gastrointestinal stromal tumors: A case report and review of the literature. J La State Med Soc 2008; 160:128-33